Effects of Vitamin D on tumor cell proliferation and migration, tumor initiation and anti-tumor immune response in head and neck squamous cell carcinomas Journal Article


Authors: Brust, L. A.; Linxweiler, M.; Schnatmann, J.; Kühn, J. P.; Knebel, M.; Braun, F. L.; Wemmert, S.; Menger, M. D.; Schick, B.; Holick, M. F.; Kuo, F.; Morris, L. G. T.; Körner, S.
Article Title: Effects of Vitamin D on tumor cell proliferation and migration, tumor initiation and anti-tumor immune response in head and neck squamous cell carcinomas
Abstract: Background: Head and neck squamous cell carcinomas (HNSCCs) are among the six most common cancers, with a constantly poor prognosis. Vitamin D has been found to have antineoplastic and immunomodulatory properties in various cancers. This study investigated the impact of Vitamin D on the initiation and progression as well as antitumor immune response in HNSCCs, both in vitro and in vivo. Methods: An immunocompetent, orthotopic oral carcinogenesis mouse model was used to examine the influence of Vitamin D3 substitution on HNSCC initiation and progression in vivo. Tumor immune infiltration was analyzed by immunohistochemistry targeting CD3, CD8, NKR-P1C, FOXP3, and CD163. Two HPV- and two HPV+ HNSCC cell lines were treated with 1,25-dihydroxyvitamin D3 to analyze effects on tumor cell proliferation, migration and transcriptomic changes using RNA-sequencing, differential gene expression and gene set enrichment analysis. Results: Vitamin D3 treatment led to a significant suppression of HNSCC initiation and progression, while also stimulating tumor immune infiltration with CD3+, CD8+ and NKR-P1C+ cells and lowering levels of M2 macrophages and Treg cells in vivo. In vitro experiments showed an inhibition of HNSCC cell proliferation and migration in HPV+ and HPV- cell lines. RNA-sequencing showed significant regulations in IL6 JAK STAT3, hypoxia signaling and immunomodulatory pathways upon Vitamin D3 treatment. Conclusion: The findings of our study highlight the promising potential of Vitamin D in the therapeutic repertoire for HNSCC patients given its immune modulating, anti-proliferative and anti-migratory properties. Clinical transferability of those in vitro and in vivo effects should be further validated in clinical trials. © 2024 The Authors
Keywords: immunohistochemistry; controlled study; human cell; nonhuman; cell proliferation; animal cell; mouse; animal tissue; gene expression; animal experiment; animal model; calcitriol; carcinogenesis; immune response; vitamin d; cell migration; vitamin supplementation; head and neck squamous cell carcinoma; tumor microenvironment; hnscc; human; article; rna sequencing; differential expression analysis; differential gene expression; rna-sequencing; gene set enrichment analysis; tme; head and neck squamous cell carcinoma cell line
Journal Title: Biomedicine and Pharmacotherapy
Volume: 180
ISSN: 0753-3322
Publisher: Elsevier Inc.  
Date Published: 2024-11-01
Start Page: 117497
Language: English
DOI: 10.1016/j.biopha.2024.117497
PROVIDER: scopus
PUBMED: 39341078
DOI/URL:
Notes: Article -- MSK Cancer Center Support Group (P30 CA008748) acknowledged in PDF -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Luc Morris
    278 Morris
  2. Fengshen Kuo
    80 Kuo